Association of Treatment Intensity and Adherence to Lipid-Lowering Therapy with Major Adverse Cardiovascular Events Among Post-MI Patients in Germany

被引：0
|
作者：
Ingo Ahrens
Artak Khachatryan
Bondo Monga
Eugen Dornstauder
Eduard Sidelnikov
机构：
[1] University of Cologne,Department of Cardiology and Medical Intensive Care, Augustinerinnen Hospital, Academic Teaching Hospital
[2] Certara,Faculty of Medicine and School of Public Health
[3] Evidence and Access (Previously-Analytica Laser),undefined
[4] Elsevier,undefined
[5] University of Lubumbashi,undefined
[6] Amgen GmbH,undefined
[7] Amgen (Europe) GmbH,undefined
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Cardiovascular disease; Lipid-lowering therapy; Myocardial infarction; Statins; Treatment adherence; Treatment intensity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2532 / 2541
页数：9
相关论文
共 50 条
  • [21] Adherence to Guideline-Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
    Armstrong, Ehrin J.
    Chen, Debbie C.
    Westin, Gregory G.
    Singh, Satinder
    McCoach, Caroline E.
    Bang, Heejung
    Yeo, Khung-Keong
    Anderson, David
    Amsterdam, Ezra A.
    Laird, John R.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (02): : e000697
  • [22] Three-year events and mortality in cardiovascular disease patients without lipid-lowering treatment
    Roman Degano, Irene
    Ramos, Rafel
    Garcia-Gil, Maria
    Zamora, Alberto
    Comas-Cufi, Marc
    Frances, Albert
    Garcia-Elias, Anna
    Marrugat, Jaume
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (19) : 2102 - 2104
  • [23] Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease
    Chan, Joyce
    Rajalingam, Tharshan
    Fossella, Jonathon
    Zhou, Hui
    Eisenberg, Naomi
    Roche-Nagle, Graham
    ANNALS OF VASCULAR SURGERY, 2020, 69 : 197 - 205
  • [24] Effects of lipid-lowering treatment intensity and adherence on cardiovascular outcomes in patients with a recent myocardial infarction: a Swedish register-based study
    Svensson, Maria K.
    Vilela, Francesc Sorio
    Leosdottir, Margret
    Banefelt, Jonas
    Lindh, Maria
    Dun, Alexander Rieem
    Norhammar, Anna
    Villa, Guillermo
    UPSALA JOURNAL OF MEDICAL SCIENCES, 2022, 127 (01)
  • [25] Discordant relationship between lipid-lowering changes and reduction of ischemic cardiovascular events (ICE) among patients with
    Holme, I.
    Rossebo, A. B.
    Malbecq, W.
    Pedersen, T. R.
    EUROPEAN HEART JOURNAL, 2009, 30 : 896 - 897
  • [26] Do Lipid-Lowering Agents Provide a Greater Reduction in Cardiovascular Events among Patients with Diabetes? RESPONSE
    Calonge, Ned
    Petitti, Diana
    ANNALS OF INTERNAL MEDICINE, 2008, 149 (11) : 841 - 842
  • [27] Adherence To Lipid-Lowering Therapy In Patients With Coronary Heart Disease From The State Of Saxony-Anhalt, Germany
    Wassmuth, Stephan
    Rohe, Katharina
    Noack, Frank
    Noutsias, Michel
    Treede, Hendrik
    Schlitt, Axel
    VASCULAR HEALTH AND RISK MANAGEMENT, 2019, 15 : 477 - 483
  • [28] ASSOCIATION OF COMBINED INTENSITY AND ADHERENCE TO STATIN/EZETIMIBE THERAPY WITH MAJOR ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CORONARY HEART DISEASE
    Mazhar, F.
    Hjemdahl, P.
    Clase, C. M.
    Johnel, K.
    Jernberg, T.
    Carrero, J. J.
    ATHEROSCLEROSIS, 2022, 355 : E301 - E302
  • [29] Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy
    Miname, Marcio H.
    Bittencourt, Marcio Sommer
    Moraes, Sergio R.
    Alves, Romulo I. M.
    Silva, Pamela R. S.
    Jannes, Cinthia E.
    Pereira, Alexandre C.
    Krieger, Jose E.
    Nasir, Khurram
    Santos, Raul D.
    JACC-CARDIOVASCULAR IMAGING, 2019, 12 (09) : 1797 - 1804
  • [30] INTENSITY OF LIPID-LOWERING THERAPY, ADHERENCE AND LDL-CHOLESTEROL GOAL ATTAINMENT IN PATIENTS WITH CORONARY HEART DISEASE
    Mazhar, F.
    Hjemdahl, P.
    Clase, C. M.
    Johnel, K.
    Jernberg, T.
    Carrero, J. J.
    ATHEROSCLEROSIS, 2022, 355 : E301 - E301
12345